Petrelintide ZUPREME-1: An Amylin Approach With a Promising Weight Signal
Petrelintide ZUPREME-1 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →Blog
RESEARCH PEPTIDES
View All Peptides →
Featured Peptides
Tesamorelin + Ipamorelin Blend
13mg
$120
Add to cart
Retatrutide + Eloralintide Blend
13mg
$100
Add to cart
Cagrilintide
10mg
$90
Add to cart
Glutathione
1500mg
$50
Add to cart
VK2735 Maintenance Trial: Could Less Frequent Treatment Preserve Weight Loss?
VK2735 VK2735 maintenance study explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Oral VK2735 VENTURE Results: A Peptide Tablet With Strong Early Weight Loss
VK2735 VENTURE-Oral explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Eloralintide Phase 2: What Selective Amylin Could Add to Weight Management
Eloralintide Eloralintide standalone phase 2 explained: study results, benefits, key insights and next steps in clear language, with links to the…
Read more →
Amycretin’s Early Injection Trial: The Study That Opened the Door for Zenagamtide
Zenagamtide Subcutaneous amycretin phase 1b/2a explained: study results, benefits, key insights and next steps in clear language, with links to the…
Read more →
Zenagamtide Diabetes Trial: One Peptide Targets GLP-1 and Amylin
Zenagamtide Zenagamtide type 2 diabetes phase 2 explained: study results, benefits, key insights and next steps in clear language, with links to the…
Read more →
CagriSema REDEFINE 2: Why Diabetes-Specific Weight-Loss Evidence Matters
CagriSema REDEFINE 2 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REDEFINE 1: The Published Evidence Behind Combination Weight Management
CagriSema REDEFINE 1 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REIMAGINE 3: Encouraging Results Alongside Basal Insulin
CagriSema REIMAGINE 3 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REIMAGINE 2: What Adding Amylin Contributed Beyond Semaglutide
CagriSema REIMAGINE 2 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REIMAGINE 1: Blood Sugar and Weight in Diet-and-Exercise-Managed Diabetes
CagriSema REIMAGINE 1 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REDEFINE 9: Why the Lower-Dose Weight-Loss Result Is Interesting
CagriSema REDEFINE 9 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
CagriSema REIMAGINE 5: A Lower-Dose Combination Meets Tirzepatide Head to Head
CagriSema REIMAGINE 5 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Retatrutide TRANSCEND-T2D-1: An Early-Diabetes Trial With Two Clear Goals
Retatrutide TRANSCEND-T2D-1 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Retatrutide and Knee Pain: TRIUMPH-4 Looks Beyond the Scale
Retatrutide TRIUMPH-4 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Retatrutide TRIUMPH-1: What the 28.3% Weight-Loss Result Really Means
Retatrutide TRIUMPH-1 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Retatrutide TRIUMPH-3: Promising Weight Results in People With Heart Disease
Retatrutide TRIUMPH-3 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
Retatrutide TRIUMPH-2: Weight Loss and Blood-Sugar Results Explained
Retatrutide TRIUMPH-2 explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →
EloraTZP Trial Results: Why Combining Amylin and Tirzepatide Matters
EloraTZP EloraTZP phase 2b explained: study results, benefits, key insights and next steps in clear language, with links to the primary evidence.
Read more →Compact Peptide Case Benefits: Four-Slot Organization and Vial Fit
Learn which vial dimensions to check for a compact four-slot case and why nominal 3 mL capacity does not guarantee the right physical fit.
Read more →
